Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients With Previous Diagnosis of Multiple Myeloma

Madan, Sumit; Dispenzieri, Angela; Lacy, Martha Q.; Buadi, Francis; Hayman, Suzanne R.; Zeldenrust, Steven R.; Kumar, Shaji K.
March 2010
Mayo Clinic Proceedings;Mar2010, Vol. 85 Issue 3, p232
Academic Journal
OBJECTIVE: To identify and assess the clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma (MM). PATIENTS AND METHODS: From a prospectively maintained database, we identified 47 patients seen between January 1, 1990, and August 31, 2008, with a diagnosis of AL amyloidosis that was made at least 6 months after MM diagnosis; these patients form the study group. RESULTS: Among the 47 patients, 36 developed typical features, 3 had atypical features, and 8 had an incidental finding of amyloidosls. Amyloid deposits were demonstrated in bone marrow, subcutaneous fat aspirate, or organ biopsy in 24, 19, and 12 patients, respectively. One organ was involved in 29 patients (62%), whereas 11 patients (23%) had involvement in more than one organ. At diagnosis of AL amyloidosis, treatment was changed or started in 22 patients, whereas the same treatment was continued In 21 patients, and no treatment data were available for the rest. The best hematologic response included partial response or better in 11 patients (23%) and stable disease in 18 patients (38%). Improvement in an organ was seen in 3 of the 21 evaluable patients. The median overall survival from diagnosis of AL amyloidosis was 9.1 months (95% confidence interval, 4-14). Of the 6 patients still alive, 2 underwent peripheral blood stem cell transplant, and none had cardiac involvement or involvement in more than one organ. CONCLUSION: Delayed onset of AL amyloidosis is rarely seen In patients with MM and requires a high index of suspicion for prompt diagnosis. Outcome of these patients is poor, especially In the presence of cardiac involvement.


Related Articles

  • Abdominal Extraosseous Lesions of Multiple Myeloma: Imaging Findings. Sedlic, Anto; Chingkoe, Christina; Lee, Kit W.; Duddalwar, Vinnay A.; Chang, Silvia D. // Canadian Association of Radiologists Journal;Feb2014, Vol. 65 Issue 1, p2 

    The article discusses a retrospective study which investigated the effect of cholecystectomy, patients age and sex on bile duct (BD) diameter. It states that the study had reviewed abdominal contrast-enhanced multidetector computed tomography and laboratory data of 290 patients with cholestasis...

  • Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells? Yano, M; Watanabe, A; Kawano, Y; Watanabe, T; Takaue, Y // Bone Marrow Transplantation;4/15/99, Vol. 23 Issue 8, p847 

    An 11-year-old girl with Ph+ CML received a marrow-ablative cytoreductive regimen, but both blood and marrow grafts obtained from her two-loci-mismatched father were rejected. At the third attempt, she was directly injected with purified CD34+ blood cells from the same donor into the bone marrow...

  • Austrian Syndrome and Multiple Myeloma: A Fatal Combination. Baig, Abdur; Moskovits, Manfred; Herrold, Edmund M.; Borra, Sonia // North American Journal of Medical Sciences;Oct2012, Vol. 4 Issue 10, p516 

    The article discusses a case wherein both Austrian Syndrome and multiple myeloma (MM) were diagnosed. It describes the case of an 84-year-old male, whose magnetic resonance imaging (MRI) showed unilateral right-sided endophthalmitis, and transesophageal echocardiogram revealed a 1.7 by 1.0...

  • Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation. Bó, Suzane Dal; Pezzi, Annelise; Amorin, Bruna; Valim, Vanessa; Bittencourt, Rosane Isabel; Silla, Lucia // ISRN Hematology;2013, p1 

    The treatment strategy in multiple myeloma (MM) is to get complete remission followed by high-dose chemotherapy and autologous Hematopoietic Stem Cell Transplantation (HSCT). Neoplastic Plasma Cells (NPCs) are CD45-/dim CD38+high, CD138+, CD19-, and CD56+high in most cases. The description of...

  • Screening for multiple myeloma. Firkin, Frank // Australian Prescriber;Aug2009, Vol. 32 Issue 4, p92 

    Patients with suspected multiple myeloma should be investigated with screening tests. They may have a paraprotein in the serum, Bence-Jones protein in the urine, or both. If these proteins are detected by a protein electrophoretogram, the patient requires further investigation to distinguish...

  • Generalized Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma. Jimenez Esteso, Maria; Verdu, Jose; de Paz, Francisco; Tarin, Fabian // Turkish Journal of Hematology;2014, Vol. 31 Issue 4, p435 

    The article presents a case study of a 42-year-old female with generalized necrobiotic xanthogranuloma and multiple myeloma multipl myeloma on the arm, abdomen, and chest. The patient was diagnosed with Immunoglobulin G (IgG)-kappa multiple myeloma. Laboratory analysis of the patient shows...

  • Phenobarbital.  // Reactions Weekly;4/12/2008, Issue 1197, p36 

    The article describes the case of a young woman who developed bone marrow aplasia while receiving treatment with phenobarbital. Her medical history included developing convergent strabismus in January 1999. Particular focus is given to the results of her bone marrow aspiration and trephine...

  • Allele-specific wild-type blocker quantitative PCR for highly sensitive detection of rare JAK2 p.V617F point mutation in primary myelofibrosis as an appropriate tool for the monitoring of molecular remission following therapy. Siebolts, Udo; Lange, Thoralf; Niederwieser, Dietger; Wickenhauser, Claudia // Journal of Clinical Pathology;Apr2010, Vol. 63 Issue 4, p370 

    Screening of JAK2 V617F point mutation becomes more and more important in monitoring of JAK2 positive MPN following stem cell transplantation. In an attempt to achieve the required high sensitivity (1:105), specifity and robustness we created an approach applicable on bone marrow biopsies where...

  • Gaucher Cells or Pseudo-Gaucher Cells: That's the Question. Şahin, Deniz Gören; Teke, Hava Üsküdar; Karagülle, Mustafa; Andıç, Neslihan; Gündüz, Eren; Işıksoy, Serap; Akay, Olga Meltem // Turkish Journal of Hematology;2014, Vol. 31 Issue 4, p428 

    The article presents a case study of a 44-year-old female with easy fatigability, oliguria, and breathlessness for 7 days. Topics discussed include analysis of bone marrow aspirate which shows numerous large cells with plentiful cytoplasm, diagnosis of multiple myeloma associated with a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics